Coverage
— → Added to coverage
Investment conviction●○○○○1 of 5
Research target—Stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 7/14/26
Market cap$10.83BSnapshot value
Research history
See all GMED changes ↗What changed
ExcelsiusGPS spine surgery robot + next-gen Excelsius3D; mid-cap profitable robotics pure-play in expanding spine surgery market (12.6% CAGR to $1.6B by 2035)
No published catalysts yet.
No published invalidation criteria yet.
No social-sentiment snapshot available.
Snapshot · 7/14/26No positioning snapshot available.
Snapshot · 7/14/26